1. Home
  2. FLGT vs NBBK Comparison

FLGT vs NBBK Comparison

Compare FLGT & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • NBBK
  • Stock Information
  • Founded
  • FLGT 2011
  • NBBK 1892
  • Country
  • FLGT United States
  • NBBK United States
  • Employees
  • FLGT N/A
  • NBBK N/A
  • Industry
  • FLGT Medical Specialities
  • NBBK
  • Sector
  • FLGT Health Care
  • NBBK
  • Exchange
  • FLGT Nasdaq
  • NBBK Nasdaq
  • Market Cap
  • FLGT 697.3M
  • NBBK 722.1M
  • IPO Year
  • FLGT 2016
  • NBBK N/A
  • Fundamental
  • Price
  • FLGT $22.51
  • NBBK $17.29
  • Analyst Decision
  • FLGT Buy
  • NBBK Buy
  • Analyst Count
  • FLGT 3
  • NBBK 1
  • Target Price
  • FLGT $25.33
  • NBBK $20.00
  • AVG Volume (30 Days)
  • FLGT 218.2K
  • NBBK 158.2K
  • Earning Date
  • FLGT 11-07-2025
  • NBBK 10-29-2025
  • Dividend Yield
  • FLGT N/A
  • NBBK 1.64%
  • EPS Growth
  • FLGT N/A
  • NBBK 341.36
  • EPS
  • FLGT N/A
  • NBBK 1.33
  • Revenue
  • FLGT $303,223,000.00
  • NBBK $179,117,000.00
  • Revenue This Year
  • FLGT $15.19
  • NBBK N/A
  • Revenue Next Year
  • FLGT $10.58
  • NBBK N/A
  • P/E Ratio
  • FLGT N/A
  • NBBK $12.86
  • Revenue Growth
  • FLGT 4.31
  • NBBK 28.24
  • 52 Week Low
  • FLGT $14.57
  • NBBK $15.09
  • 52 Week High
  • FLGT $23.57
  • NBBK $21.05
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 53.81
  • NBBK 36.24
  • Support Level
  • FLGT $22.09
  • NBBK $16.84
  • Resistance Level
  • FLGT $23.09
  • NBBK $18.21
  • Average True Range (ATR)
  • FLGT 0.65
  • NBBK 0.39
  • MACD
  • FLGT -0.09
  • NBBK -0.08
  • Stochastic Oscillator
  • FLGT 41.99
  • NBBK 23.95

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About NBBK NB Bancorp Inc.

NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.

Share on Social Networks: